7-87431528-C-T

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 4P and 13B. PM1PP2PP3BP4_StrongBP6BS1BS2

The NM_000443.4(ABCB4):​c.1769G>A​(p.Arg590Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0067 in 1,614,056 control chromosomes in the GnomAD database, including 45 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R590P) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0060 ( 4 hom., cov: 32)
Exomes 𝑓: 0.0068 ( 41 hom. )

Consequence

ABCB4
NM_000443.4 missense

Scores

7
8
2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:2U:11B:4O:1

Conservation

PhyloP100: 7.86

Publications

36 publications found
Variant links:
Genes affected
ABCB4 (HGNC:45): (ATP binding cassette subfamily B member 4) The membrane-associated protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the MDR/TAP subfamily. Members of the MDR/TAP subfamily are involved in multidrug resistance as well as antigen presentation. This gene encodes a full transporter and member of the p-glycoprotein family of membrane proteins with phosphatidylcholine as its substrate. The function of this protein has not yet been determined; however, it may involve transport of phospholipids from liver hepatocytes into bile. Alternative splicing of this gene results in several products of undetermined function. [provided by RefSeq, Jul 2008]
ABCB4 Gene-Disease associations (from GenCC):
  • progressive familial intrahepatic cholestasis type 3
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, ClinGen
  • gallbladder disease 1
    Inheritance: SD, AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae)
  • pancreatitis
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

PM1
In a hotspot region, there are 3 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 5 uncertain in NM_000443.4
PP2
Missense variant in the ABCB4 gene, where missense mutations are typically associated with disease (based on misZ statistic). The gene has 32 curated pathogenic missense variants (we use a threshold of 10). The gene has 6 curated benign missense variants. Gene score misZ: 1.9749 (below the threshold of 3.09). Trascript score misZ: 3.5425 (above the threshold of 3.09). GenCC associations: The gene is linked to gallbladder disease 1, progressive familial intrahepatic cholestasis type 3, pancreatitis.
PP3
Multiple lines of computational evidence support a deleterious effect 8: AlphaMissense, BayesDel_noAF, Cadd, Dann, Eigen, phyloP100way_vertebrate, REVEL, REVEL [when BayesDel_addAF, max_spliceai, FATHMM_MKL, MetaRNN, MutationTaster was below the threshold]
BP4
Computational evidence support a benign effect (MetaRNN=0.021850199).
BP6
Variant 7-87431528-C-T is Benign according to our data. Variant chr7-87431528-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 13697.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00604 (920/152262) while in subpopulation NFE AF = 0.00767 (522/68014). AF 95% confidence interval is 0.00713. There are 4 homozygotes in GnomAd4. There are 393 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 4 SD,AR,AD gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000443.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ABCB4
NM_000443.4
MANE Select
c.1769G>Ap.Arg590Gln
missense
Exon 15 of 28NP_000434.1P21439-2
ABCB4
NM_018849.3
c.1769G>Ap.Arg590Gln
missense
Exon 15 of 28NP_061337.1P21439-1
ABCB4
NM_018850.3
c.1769G>Ap.Arg590Gln
missense
Exon 15 of 27NP_061338.1P21439-3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ABCB4
ENST00000649586.2
MANE Select
c.1769G>Ap.Arg590Gln
missense
Exon 15 of 28ENSP00000496956.2P21439-2
ABCB4
ENST00000265723.8
TSL:1
c.1769G>Ap.Arg590Gln
missense
Exon 15 of 28ENSP00000265723.4P21439-1
ABCB4
ENST00000359206.8
TSL:1
c.1769G>Ap.Arg590Gln
missense
Exon 15 of 28ENSP00000352135.3P21439-2

Frequencies

GnomAD3 genomes
AF:
0.00605
AC:
920
AN:
152144
Hom.:
4
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00584
Gnomad AMI
AF:
0.0143
Gnomad AMR
AF:
0.00726
Gnomad ASJ
AF:
0.000576
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00132
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00767
Gnomad OTH
AF:
0.00718
GnomAD2 exomes
AF:
0.00449
AC:
1127
AN:
251094
AF XY:
0.00448
show subpopulations
Gnomad AFR exome
AF:
0.00535
Gnomad AMR exome
AF:
0.00512
Gnomad ASJ exome
AF:
0.000199
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00222
Gnomad NFE exome
AF:
0.00676
Gnomad OTH exome
AF:
0.00620
GnomAD4 exome
AF:
0.00677
AC:
9892
AN:
1461794
Hom.:
41
Cov.:
31
AF XY:
0.00654
AC XY:
4755
AN XY:
727210
show subpopulations
African (AFR)
AF:
0.00559
AC:
187
AN:
33470
American (AMR)
AF:
0.00541
AC:
242
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.000153
AC:
4
AN:
26132
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39696
South Asian (SAS)
AF:
0.000197
AC:
17
AN:
86250
European-Finnish (FIN)
AF:
0.00217
AC:
116
AN:
53420
Middle Eastern (MID)
AF:
0.00277
AC:
16
AN:
5768
European-Non Finnish (NFE)
AF:
0.00804
AC:
8940
AN:
1111946
Other (OTH)
AF:
0.00613
AC:
370
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
604
1209
1813
2418
3022
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
352
704
1056
1408
1760
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00604
AC:
920
AN:
152262
Hom.:
4
Cov.:
32
AF XY:
0.00528
AC XY:
393
AN XY:
74432
show subpopulations
African (AFR)
AF:
0.00585
AC:
243
AN:
41558
American (AMR)
AF:
0.00725
AC:
111
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.000576
AC:
2
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4816
European-Finnish (FIN)
AF:
0.00132
AC:
14
AN:
10604
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00767
AC:
522
AN:
68014
Other (OTH)
AF:
0.00711
AC:
15
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
49
98
147
196
245
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00666
Hom.:
41
Bravo
AF:
0.00663
TwinsUK
AF:
0.00701
AC:
26
ALSPAC
AF:
0.0127
AC:
49
ESP6500AA
AF:
0.00635
AC:
28
ESP6500EA
AF:
0.00860
AC:
74
ExAC
AF:
0.00418
AC:
507
Asia WGS
AF:
0.00144
AC:
5
AN:
3478
EpiCase
AF:
0.00725
EpiControl
AF:
0.00753

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
4
1
not provided (5)
1
1
1
Cholestasis, intrahepatic, of pregnancy, 3 (3)
-
2
1
not specified (3)
1
1
-
Low phospholipid associated cholelithiasis (2)
-
1
1
Progressive familial intrahepatic cholestasis type 3 (2)
-
1
-
Progressive familial intrahepatic cholestasis type 1 (1)
-
1
-
Progressive familial intrahepatic cholestasis type 3;C2609268:Low phospholipid associated cholelithiasis;C3554241:Cholestasis, intrahepatic, of pregnancy, 3 (1)
-
-
-
ABCB4-related disorder (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.81
BayesDel_addAF
Benign
-0.044
T
BayesDel_noAF
Pathogenic
0.18
CADD
Pathogenic
28
DANN
Pathogenic
1.0
DEOGEN2
Pathogenic
0.84
D
Eigen
Pathogenic
0.78
Eigen_PC
Pathogenic
0.75
FATHMM_MKL
Uncertain
0.94
D
LIST_S2
Uncertain
0.86
D
MetaRNN
Benign
0.022
T
MetaSVM
Uncertain
0.38
D
MutationAssessor
Uncertain
2.1
M
PhyloP100
7.9
PrimateAI
Uncertain
0.57
T
PROVEAN
Uncertain
-3.6
D
REVEL
Pathogenic
0.71
Sift
Uncertain
0.0010
D
Sift4G
Uncertain
0.0020
D
Polyphen
1.0
D
Vest4
0.85
MVP
0.87
MPC
1.0
ClinPred
0.039
T
GERP RS
5.5
Varity_R
0.78
gMVP
0.83
Mutation Taster
=94/6
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs45575636; hg19: chr7-87060844; COSMIC: COSV99052096; COSMIC: COSV99052096; API